KCNG2 inhibitors are a class of chemical compounds that selectively inhibit the KCNG2 protein, a subunit of the voltage-gated potassium channel family. KCNG2, also known as Kv6.2, is part of a diverse group of ion channels that regulate potassium ion flux across cell membranes, contributing to the maintenance of the resting membrane potential and shaping the action potential in excitable cells. As a modulatory subunit, KCNG2 does not form functional channels by itself but co-assembles with other Kv subunits, particularly those from the Kv2 family, to form heteromeric channels with distinct biophysical and pharmacological properties. Inhibitors of KCNG2 are therefore key tools in understanding the specific contributions of this subunit to the overall function of voltage-gated potassium channels. The modulation of these channels by KCNG2 inhibitors can provide insights into the physiological roles of KCNG2-containing channels in various cellular processes, including electrical signaling, cell proliferation, and apoptosis.
The design and development of KCNG2 inhibitors often involve high-throughput screening techniques and structure-activity relationship (SAR) studies to identify compounds that specifically target the KCNG2 subunit without affecting other potassium channels. This specificity is crucial, as it allows researchers to delineate the role of KCNG2 in cellular electrophysiology and its impact on cell behavior in both normal and pathological states. Studies using KCNG2 inhibitors have demonstrated that these compounds can modulate neuronal excitability and synaptic transmission, making them valuable tools for neurophysiological research. Additionally, these inhibitors can be used to investigate the contributions of KCNG2-containing channels to the electrical properties of other excitable cells, such as cardiac and smooth muscle cells. By selectively blocking KCNG2, researchers can better understand the complex network of potassium channels and their regulation, ultimately contributing to a more comprehensive understanding of cellular excitability and signaling.
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
4-Aminopyridine | 504-24-5 | sc-202421 sc-202421B sc-202421A | 25 g 1 kg 100 g | $37.00 $1132.00 $120.00 | 3 | |
電位依存性カリウムチャネルをブロックし、KCNG2によって調節されているチャネルに影響を及ぼす可能性がある。 | ||||||
Quinidine | 56-54-2 | sc-212614 | 10 g | $102.00 | 3 | |
様々なカリウムチャネルをブロックし、KCNG2関連のチャネル活性に影響を及ぼす可能性がある。 | ||||||
Clofilium tosylate | 92953-10-1 | sc-391228 sc-391228A | 25 mg 100 mg | $428.00 $1020.00 | 1 | |
様々なカリウムチャネルを阻害し、KCNG2調節チャネルに影響を及ぼす可能性がある。 | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
主にカルシウム拮抗薬であるが、カリウムチャネルに対して標的外作用を示すことがある。 | ||||||